San Diego, CA, United States of America

Thomas J Cummins

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas J Cummins. Retrieved from https://idiyas.com/inventor/thomas-j-cummins-oigisp6z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas J Cummins: Innovator in Hemoglobinopathy Treatment

Introduction

Thomas J Cummins is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hemoglobinopathies. His innovative work has led to the development of compounds that offer new methods for prevention and treatment.

Latest Patents

Thomas J Cummins holds a patent for "Compounds and their use for treatment of hemoglobinopathies." This patent discloses compounds and methods aimed at preventing and treating hemoglobinopathies. Additionally, it includes pharmaceutical compositions that utilize these compounds for effective treatment.

Career Highlights

Cummins is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to focus on groundbreaking research and development in the medical field.

Collaborations

Some of his notable coworkers include Scott Arne Johnson and Hannah L Powers. Their collaborative efforts contribute to the advancement of innovative treatments in the pharmaceutical industry.

Conclusion

Thomas J Cummins exemplifies the spirit of innovation in the medical field, particularly through his work on hemoglobinopathy treatments. His contributions are paving the way for new therapeutic options that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…